• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. The new face of enterohaemorrhagic Escherichia coli infections

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Extract, edited.]


Eurosurveillance, Volume 16, Issue 25, 23 June 2011
Editorials
The new face of enterohaemorrhagic Escherichia coli infections



A Jansen ()<SUP>1</SUP>, J T Kielstein<SUP>2</SUP>
  1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
  2. Department of Nephrology and Hypertension, Medical School Hannover, Germany
<HR>
Citation style for this article: Jansen A, Kielstein JT. The new face of enterohaemorrhagic Escherichia coli infections. Euro Surveill. 2011;16(25):pii=19898. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19898
Date of submission: 22 June 2011
<HR>The unprecedented outbreak of Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) O104:H4 in Germany in May and June 2011 displayed several novel epidemiological, microbiological and clinical features. Infection with STEC/VTEC, also referred to as enterohaemorrhagic E. coli (EHEC), with or without haemorrhagic uraemic syndrome (HUS), which is usually a disease of pre-school children and equally distributed among the sexes, affected in the current outbreak mostly women over the age of 20 years (87%). In addition, several intriguing microbiological characteristics of the new epidemic strain have just been published [1,2].

(?)

-
------
 
Back
Top Bottom